HLS THERAPEUTICS INC.
Research HLS THERAPEUTICS INC. (74D) on Bullrun: market cap EUR 69.43M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker74D
- ExchangeF
- CountryCanada
- SectorHealthcare
- IndustryDrug Manufacturers - Specialty & Generic
- CurrencyEUR
- Market capEUR 69.43M
- Financial periodQ1 2026
- RevenueUSD 12.86M
- Net income-USD 2.30M
- Free cash flowUSD 5.98M
- Gross margin79.2%
Valuation Snapshot
latest market cap is EUR 69.43M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 55.50M | -USD 12.43M | USD 15.43M | 81.8% | -0.39 | USD 11.72M | USD 49.82M | USD 61.67M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-14 | EUR 69.43M | n/a | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 EUR.
About HLS THERAPEUTICS INC.
HLS Therapeutics Inc., a specialty pharmaceutical company, acquires and commercializes pharmaceutical products for the treatment of psychiatric disorders and cardiovascular disease in Canada, the United States, and internationally. The company offers Clozaril (clozapine tablets), an atypical antipsychotic to manage symptoms of treatment-resistant schizophrenia; CSAN Pronto device, which enhances and simplifies the mandatory safety blood monitoring process for patients that are prescribed Clozaril;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is HLS THERAPEUTICS INC.'s market cap?
HLS THERAPEUTICS INC.'s market capitalization is EUR 69.43M.
What does HLS THERAPEUTICS INC. do?
HLS Therapeutics Inc., a specialty pharmaceutical company, acquires and commercializes pharmaceutical products for the treatment of psychiatric disorders and cardiovascular disease in Canada, the United States, and internationally.